[Growth hormone secretion induced by L-Dopa and a dopa decarboxylase inhibitor blocked by free fatty acids].
D000293:Adolescent; D000328:Adult; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001545:Benserazide / Q000494:pharmacology*; D004357:Drug Synergism; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology*; D005260:Female; D013006:Growth Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D007980:Levodopa / Q000494:pharmacology*; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects / Q000378:metabolism; D012636:Secretory Rate / Q000187:drug effects
D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D005230:Fatty Acids, Nonesterified; D006834:Hydrazines; D007980:Levodopa; D001545:Benserazide; D013006:Growth Hormone
Inhibición por los ácidos grasos libres (FFA) de la secreción de hormona de crecimiento (GH) inducida por la L-Dopa más un inhibidor de la dopa-decarboxilasa.